Company Filing History:
Years Active: 2020-2025
Title: Innovator in Cancer Research: The Contributions of Mingye Feng
Introduction
Mingye Feng, based in Mountain View, CA, is an accomplished inventor with a remarkable portfolio of three patents. His work centers on groundbreaking therapeutic methods that target cancer treatment, showcasing his commitment to enhancing the efficacy of phagocytosis in cancer cells.
Latest Patents
One of the most significant patents by Mingye Feng is focused on the use of TLR agonists and anti-CD47 agents. This innovation provides therapeutic and diagnostic methods that induce the expression of calreticulin on phagocytic cells. The methods involve macrophage-mediated programmed cell removal (PrCR), where PrCR can be increased by contacting a phagocytic cell with a toll-like receptor (TLR) agonist. Alternatively, PrCR can be down-regulated by utilizing an inhibitor of Bruton's tyrosine kinase (BTK). Notably, some embodiments involve combining an activator of TLR signaling or a BTK agonist with CD47 blockade. These pioneering approaches are critical in advancing cancer therapies.
Career Highlights
Mingye Feng's professional journey is marked by his affiliation with Leland Stanford Junior University, where he has contributed significantly to cancer research. His innovative thinking and dedication have been crucial in shaping new methodologies for treating cancer, reflecting his expertise in the field.
Collaborations
Throughout his career, Mingye has collaborated with esteemed researchers, including Irving L. Weissman and Jens-Peter Volkmer. These partnerships highlight the collaborative spirit of scientific research and the importance of interdisciplinary approaches in developing effective cancer treatments.
Conclusion
Mingye Feng continues to make notable contributions to the field of cancer research through his inventions. His patents, centered around enhancing the immune response against cancer cells, mark a significant step forward in therapeutic innovations. As he progresses in his career, the scientific community eagerly anticipates further advancements from this visionary inventor.